| ACP | Insured Package Advisory Committee |
| ATMP | Advanced Therapeutic Medicinal Products |
| CD | Commission Decision on Marketing Authorisation |
| CHMP | Committee for Human use of Medicinal Products |
| CieBAG | Committee Assessment of Add-on Medication |
| EMA | European Medicines Agency |
| EU | European Union |
| EUnetHTA | European Network for HTA |
| HTA | Health Technology Assessment |
| HTACG | HTA Coordination Group |
| HTAR | HTA Regulation (EU) 2021/2282 |
| HTD | Health Technology Developer |
| IVD | In-Vitro Diagnostic MD |
| JCA | Joint Clinical Assessment |
| JSC | Joint Scientific Consultation |
| MAA | Marketing Authorisation Application |
| MD | Medical Device |
| MS | Member State |
| OWIZ | Development & International Affairs |
| PICO | Patient/Intervention/Comparator(s)/Outcome(s) |
| WAR | Scientific Advisory Board |
| ZIN | Zorginstituut Nederland; the Dutch National Healthcare Institute |